Pharmacyclics Llc.
Clinical trials sponsored by Pharmacyclics Llc., explained in plain language.
-
New hope for lymphoma patients: drug combo shows promise in major trial
Disease control CompletedThis study tested whether adding the drug ibrutinib to standard rituximab treatment works better than rituximab alone for people newly diagnosed with follicular lymphoma. Researchers enrolled 445 older adults or those with other health conditions to compare how long patients stay…
Phase: PHASE3 • Sponsor: Pharmacyclics LLC. • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
New hope for kids battling transplant complications
Disease control CompletedThis study aimed to find a safe and effective dose of the drug ibrutinib for children and young adults with chronic graft-versus-host disease (cGVHD), a serious complication that can occur after a stem cell transplant. It involved 59 participants aged 1 to 22 years who had modera…
Phase: PHASE1, PHASE2 • Sponsor: Pharmacyclics LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC